“This podcast used to be ok but there’s only so many times you can say ’XPF are growing, they’re going to be a midcap soon’, ‘polx will have the fda approval coming’ or ‘biome was hit with the same supply chain issues all customers have faced’.
The guests/co presenters used to be ok but you can tell their portfolios are down considerably from last year and they’ve just lost interest.
It would be great if there could be discussion about the wider market, different shares and/or guests perhaps?”
dptaylor5 via Apple Podcasts ·
Great Britain ·
04/26/22